CN112426511A - 一种治疗非酒精性脂肪肝的中药组合物 - Google Patents
一种治疗非酒精性脂肪肝的中药组合物 Download PDFInfo
- Publication number
- CN112426511A CN112426511A CN202011512895.9A CN202011512895A CN112426511A CN 112426511 A CN112426511 A CN 112426511A CN 202011512895 A CN202011512895 A CN 202011512895A CN 112426511 A CN112426511 A CN 112426511A
- Authority
- CN
- China
- Prior art keywords
- parts
- fatty liver
- liver
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 8
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 12
- 235000008397 ginger Nutrition 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 235000008434 ginseng Nutrition 0.000 claims description 10
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 9
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 9
- 240000001851 Artemisia dracunculus Species 0.000 claims description 9
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 9
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 9
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims description 9
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 9
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims description 9
- 239000001138 artemisia absinthium Substances 0.000 claims description 9
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 9
- 240000004980 Rheum officinale Species 0.000 claims description 8
- 235000008081 Rheum officinale Nutrition 0.000 claims description 8
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 7
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 7
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 7
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 7
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 7
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 244000273928 Zingiber officinale Species 0.000 claims description 3
- 244000131316 Panax pseudoginseng Species 0.000 claims 2
- 210000004369 blood Anatomy 0.000 abstract description 27
- 239000008280 blood Substances 0.000 abstract description 27
- 210000004185 liver Anatomy 0.000 abstract description 21
- 210000000952 spleen Anatomy 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 15
- 238000005728 strengthening Methods 0.000 abstract description 3
- 244000163122 Curcuma domestica Species 0.000 abstract description 2
- 235000003392 Curcuma domestica Nutrition 0.000 abstract description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract description 2
- 235000003373 curcuma longa Nutrition 0.000 abstract description 2
- 235000013976 turmeric Nutrition 0.000 abstract description 2
- 239000008767 xiaochaihu Substances 0.000 abstract description 2
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 241000234314 Zingiber Species 0.000 description 9
- 210000000232 gallbladder Anatomy 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 241000208340 Araliaceae Species 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 244000132619 red sage Species 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 208000004930 Fatty Liver Diseases 0.000 description 5
- 206010019708 Hepatic steatosis Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 208000010706 fatty liver disease Diseases 0.000 description 5
- 230000003908 liver function Effects 0.000 description 5
- 231100000240 steatosis hepatitis Toxicity 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 3
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 3
- 241001522129 Pinellia Species 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010019668 Hepatic fibrosis Diseases 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000012839 conversion disease Diseases 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000092668 Artemisia capillaris Species 0.000 description 1
- 235000008658 Artemisia capillaris Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 244000236521 Bupleurum rotundifolium Species 0.000 description 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010072268 Drug-induced liver injury Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 125000003338 L-glutaminyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H] 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010065951 Retrograde menstruation Diseases 0.000 description 1
- 241000219061 Rheum Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 231100000594 drug induced liver disease Toxicity 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012317 liver biopsy Methods 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical group 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗非酒精性脂肪肝的中药组合物。该方是在小柴胡汤的基础上加丹参、大黄、茵陈、郁金而成,诸药合用,可使气机上通下达,内外和调,共奏疏肝健脾、降浊化瘀之功,治疗非酒精性脂肪肝疗效显著。
Description
技术领域
本发明涉及一种中药技术领域,尤其是涉及一种用于治疗非酒精性脂肪肝的中药组合物。
背景技术
非酒精性脂肪性肝病(Nonalcoholic-fatty-liver-disease,NAFLD)是导致肝功能异常的重要因素,其发病与肥胖、胰岛素抵抗及糖尿病有关,也与心血管病密切相关。非酒精性脂肪肝(肝细胞内甘油三酯的过量沉积)是NAFLD诊断的标志。如果不及时治疗,非酒精性脂肪肝可发展成严重的肝病,如肝硬化,甚至肝细胞性肝癌。对于非酒精性脂肪肝的治疗,目前尚无针对性的化学合成药物,而中医药治疗具有独特优势。中医认为,非酒精性脂肪肝多属肝郁脾虚、浊瘀阻络之证,治以疏肝健脾、降浊化瘀为法,本方是在小柴胡汤的基础上加丹参、大黄、茵陈、郁金而成,诸药合用,可使气机上通下达,内外和调,共奏疏肝健脾、降浊化瘀之功。本发明制备得到的中药组合物治疗非酒精性脂肪肝,取得了良好效果。
发明内容
本发明目的在于提供一种安全有效的治疗非酒精性脂肪肝的中药组合物。
本发明的另一目的是阐明该中药组合物治疗非酒精性脂肪肝的作用机理。
制备本发明中药组合物由以下原料药制成:柴胡9-15份、黄芩6-12份、法半夏6-12份、人参3-9份、丹参15-21份、大黄3-9份、茵陈15-21份、郁金12-18份、炙甘草3-9份、大枣9-15份、生姜6-12份。
本发明所提供的中药组合物原料药的最佳重量份是:柴胡12份、黄芩9份、法半夏9份、人参6份、丹参18份、大黄6份、茵陈18份、郁金15份、炙甘草6份、大枣12份、生姜9份。
本发明中药的药理作用如下:
柴胡:味苦、辛,性微寒,归肝、胆经,具有和解退热、疏肝解郁、升阳举陷之功,主治寒热往来、外感发热、肝郁气滞、气虚下陷、久泻脱肛等病证。
黄芩:味苦,性寒,归肺、胆、脾、大肠、小肠经,具有清热燥湿、泻火解毒、凉血止血之功,主治湿温、泻痢、黄疸、肺热证、少阳证、疮疡肿毒、血热吐衄等病证。
法半夏:味辛,性温,归脾、胃、肺经,具有燥湿化痰、降逆止呕、消痞散结之功,主治咳嗽气逆、痰多质稀、湿痰眩晕、恶心呕吐、结胸、梅核气、痈疽肿毒、毒蛇咬伤等病症。
人参:味甘、微苦,性微温,归心、肺、脾经,具有大补元气、补脾益肺、生津、安神益智之功,主治元气虚脱证、肺脾心肾气虚证、热病气虚津伤口渴及消渴等病症。
丹参:味苦,性微寒,归心、肝经,具有活血化瘀、调经止痛、凉血消痈、清心除烦之功,主治各科瘀血阻滞病证、月经不调、跌打损伤、风湿痹症、疮疡痈肿、烦躁失眠等病证。
大黄:味苦,性寒,归脾、胃、大肠、肝、心包经,具有泻下攻积、清热泻火、凉血解毒、逐瘀通经之功,主治肠道积滞、大便秘结、头痛目赤、咽喉肿痛、齿龈肿痛、热毒疮疡及烧伤、血瘀证、黄疸、淋病等病证。
茵陈:味苦、辛,性微寒,归脾、胃、肝、胆经,具有利湿退黄、解毒疗疮之功,主治黄疸、湿疮瘙痒等病症。
郁金:味辛、苦,性寒,归肝、胆、心经,具有活血行气止痛、化痰解郁开窍、利胆退黄、清热凉血之功,主治气滞血瘀引起的胸、胁、腹等诸痛证;热病神昏、癫痫痰闭、肝胆湿热证、黄疸、胆石症,以及血热妄行引起的吐血、衄血、尿血及妇女倒经等出血病证。
炙甘草:味甘,性平,归心、肺、脾、胃经,具有补脾益气、祛痰止咳、缓急止痛、清热解毒、调和药性之功,主治脾胃气虚证、心悸气短、痈肿疮疡、咳嗽气喘、脘腹四肢挛急疼痛、药食中毒等病症。
大枣:味甘,性温,归脾、胃、心经,具有补中益气、养血安神、缓和药性之功,主治脾胃虚弱、血虚萎黄、脏躁等病症。
生姜:味辛,性温,归肺、脾、胃经,具有发汗解表、温中止呕、温肺化饮之功,主治风寒感冒咳嗽、胃寒呕吐、脾胃虚寒等病证。此外生姜还有解半夏、天南星及鱼蟹毒等作用。
本发明所述的中药组合物,从组方来看,方中柴胡苦平,疏肝解郁,能解心腹肠胃间的结气,推陈致新;黄芩苦寒泄热;半夏辛开苦降,配柴胡则升,配黄芩则降,合茵陈渗湿降浊,有升清降浊之妙;丹参活血散瘀,郁金行气解郁、凉血破瘀,二者配伍可解肝经郁滞之瘀;生姜、半夏配伍,二者辛散疏通气郁,助柴胡以解郁,又可协同茵陈渗湿降浊,同时还有和胃降逆止呕之效;人参、大枣、甘草补中气和营卫,可健脾培元,使正胜邪却,扶正不留邪,还可防止少阳之邪内传太阴。现代药理研究表明,小柴胡汤可通过多个途径达到保护肝细胞、防止肝损伤、抑制肝纤维化和免疫调节等作用,而丹参、茵陈、郁金等药味均有很好的保肝、降脂、抗肝纤维化等作用。故诸药合用,可使气机上通下达,内外和调,共奏疏肝健脾、降浊化瘀之功,在非酒精性脂肪肝防治中具有良好的治疗效果。
本发明所述的中药组合物使用于2016年至2019年临床观察非酒精性脂肪肝症68例患者,临床报告如下:
1.一般资料
68例患者中,女性36例,男性32例,年龄最小29岁,最大65岁,平均年龄43.9岁。
2.诊断标准
参照《中医病证诊断疗效标准》:
j饮酒史或饮酒折合乙醇量,男性每周<40g。②排除病毒性肝炎、药物性肝病、全胃肠性营养、肝豆状核变性等可导致脂肪肝的特定疾病。③除原发性疾病临床表现外,可伴乏力、消化不良、肝区隐痛、肝脾肿大等非特异性症状及体征。④可有体质量超重和(或)内脏性肥胖、空腹血糖增高、血脂紊乱、高血压等代谢综合征相关变化。⑤血清ALT、AST、γ-GGT水平可有轻至中轻度增高(<5倍正常值上限),通常以ALT增加为主。⑥肝脏影像学表现符合弥漫性脂肪肝影像学诊断要点。⑦肝活体组织检查其组织学改变符合脂肪肝的病理学诊断要点。以上7项具备①-⑤项和第或第⑦项中任一项可确定诊断。
3.治疗方法
3.1 处方:柴胡12g、黄芩9g、法半夏9g、人参6g、丹参18g、大黄6g、茵陈18g、郁金15g、炙甘草6g、大枣12g、生姜9g。
3.2 服用方法:按照常规煎药方法制成汤剂,每日1剂,分3次服用,30天为1疗程。
3.3 观察指标;记录患者症状、体征及饮食及体质量的变化。治疗前后行B超检查肝、胆、胰、脾,抽取静脉血检测血清血脂、肝功能水平,包括总胆固醇(TC)、甘油三酯(TG)、丙氨酸氨基转氨酶(ALT)、天门冬氨酸氨基转氨酶(AST)、γ-谷氨酰转肽酶(γ-GGT)。
4. 治疗结果
4.1参照《中医病证诊断疗效标准》:
临床治愈:临床症状及体征消失,肝脏B超或CT检查、实验室检查恢复正常;
显效:临床症状及体征明显改善,肝脏B超或CT检查,好转明显,实验室检查的各项指标下降41.20%以上;
未愈:临床症状及体征改善不明显,肝脏B超或CT检查治疗前后无明显变化,实验的各项指标无明显下降。
4.2结果:
68例患者中,临床治愈39例(57.35%),显效26例(38.24%),未愈3例(4.41%),总有效率为95.59%。
5. 典型病例
5.1朱某某,女,43岁,2周前出现食欲减退,神疲乏力,右胁隐隐作痛,遂至医院就诊,腹部彩超检查提示轻度脂肪肝。肝功能显示:丙氨酸氨基转氨酶(ALT)62U/L,天门冬氨酸氨基转氨酶(AST)48U/L,γ-谷氨酰转肽酶 (γ-GGT)63U/L;血脂:总胆固醇(TC)6.92mmol/L,甘油三酯(TG)6.52mmol/L。舌淡红苔白偏腻,脉弦细。辨证为肝郁脾虚、浊瘀阻络证,治以疏肝健脾、降浊化瘀为法,服用本发明药物,每日1剂,水煎服,服用2个疗程后,复查肝功、血脂均正常,B超显示肝胆胰脾未见明显异常,痊愈。半年后随访无复发。
5.2刘某某,男,61岁。平素性格内向,不饮酒,形体肥胖,述1月前无明显诱因出现右上腹隐痛,未引起重视,1周前右上腹隐痛加重,伴有食少腹胀,遂至医院就诊,腹部彩超检查提示为中度脂肪肝。肝功能显示:丙氨酸氨基转氨酶(ALT)138U/L,天门冬氨酸氨基转氨酶(AST)76U/L,γ-谷氨酰转肽酶 (γ-GGT) 129U/L;血脂:总胆固醇(TC)10.35mmol/L,甘油三酯(TG)8.26mmol/L。舌淡暗苔白偏腻,脉沉弦细。辨证为肝郁脾虚、浊瘀阻络证,治以疏肝健脾、降浊化瘀为法,服用本发明药物,每日1剂,水煎服,服用3个疗程后,复查肝功、血脂均正常,B超显示肝胆胰脾未见明显异常,痊愈。半年后随访无复发。
具体实施方式
下面结合实施例对本发明作进一步说明,下述该实施例仅用于说明而对本发明没有限制。
实施例1:一种治疗非酒精性脂肪肝的中药组合物,它是由下述原料药制成:柴胡12g、黄芩9g、法半夏8g、人参6g、丹参18g、大黄6g、茵陈18g、郁金15g、炙甘草6g、大枣12g、生姜9g。
实施例2:一种治疗非酒精性脂肪肝的中药组合物,它是由下述原料药制成:柴胡13g、黄芩9g、法半夏9g、人参6g、丹参18g、大黄6g、茵陈16g、郁金15g、炙甘草6g、大枣12g、生姜9g。
实施例3:一种治疗非酒精性脂肪肝的中药组合物,它是由下述原料药制成:柴胡15g、黄芩9g、法半夏8g、人参6g、丹参18g、大黄6g、茵陈15g、郁金15g、炙甘草6g、大枣12g、生姜9g。
Claims (3)
1.一种治疗非酒精性脂肪肝的中药组合物,其特征在于包括以下原料药,柴胡9-15份、黄芩6-12份、法半夏6-12份、人参3-9份、丹参15-21份、大黄3-9份、茵陈15-21份、郁金12-18份、炙甘草3-9份、大枣9-15份、生姜6-12份。
2.根据权利要求1所述的中药组合物,其特征在于包括以下原料药:柴胡12份、黄芩9份、法半夏9份、人参6份、丹参18份、大黄6份、茵陈18份、郁金15份、炙甘草6份、大枣12份、生姜9份。
3.权利要求1所述的中药组合物在治疗用于非酒精性脂肪肝病中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011512895.9A CN112426511A (zh) | 2020-12-20 | 2020-12-20 | 一种治疗非酒精性脂肪肝的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011512895.9A CN112426511A (zh) | 2020-12-20 | 2020-12-20 | 一种治疗非酒精性脂肪肝的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112426511A true CN112426511A (zh) | 2021-03-02 |
Family
ID=74696842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011512895.9A Pending CN112426511A (zh) | 2020-12-20 | 2020-12-20 | 一种治疗非酒精性脂肪肝的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112426511A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115887545A (zh) * | 2022-11-25 | 2023-04-04 | 深圳市人民医院 | 一种中药组合物及包含该中药组合物的产品、制备方法及其用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1569054A (zh) * | 2003-07-22 | 2005-01-26 | 天津天士力制药股份有限公司 | 一种小柴胡汤滴丸 |
CN101716328A (zh) * | 2009-08-07 | 2010-06-02 | 南通精华制药股份有限公司 | 大柴胡颗粒在制备治疗脂肪肝药物中的应用 |
-
2020
- 2020-12-20 CN CN202011512895.9A patent/CN112426511A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1569054A (zh) * | 2003-07-22 | 2005-01-26 | 天津天士力制药股份有限公司 | 一种小柴胡汤滴丸 |
CN101716328A (zh) * | 2009-08-07 | 2010-06-02 | 南通精华制药股份有限公司 | 大柴胡颗粒在制备治疗脂肪肝药物中的应用 |
Non-Patent Citations (3)
Title |
---|
李淑珠等: ""加味小柴胡汤治疗非酒精性脂肪肝的临床观察"", 《光明中医》 * |
王金瑞: "降脂舒肝汤治疗脂肪肝30例疗效分析", 《基层医学论坛》 * |
许雪莲等: ""金实治疗非酒精性脂肪肝经验"", 《河南中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115887545A (zh) * | 2022-11-25 | 2023-04-04 | 深圳市人民医院 | 一种中药组合物及包含该中药组合物的产品、制备方法及其用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104491415A (zh) | 一种治疗慢性阻塞性肺疾病稳定期的药物及其制备方法 | |
CN104644915A (zh) | 一种治疗酒精性肝病的药物组合物及其制备方法和用途 | |
CN117224645B (zh) | 一种具有治疗糖尿病肾病的中药复方组合物及其制备方法与应用 | |
TW202406564A (zh) | 一種中藥組合物及其用途 | |
CN109692309B (zh) | 治疗非酒精性脂肪肝祛湿活血中药 | |
CN103920074A (zh) | 一种治疗乙肝的中药组合物 | |
CN101422558B (zh) | 一种治疗梅核气的中药 | |
CN112426511A (zh) | 一种治疗非酒精性脂肪肝的中药组合物 | |
CN104352989A (zh) | 一种治疗黄疸的药物组合物 | |
CN101766720B (zh) | 一种治疗肝病的药物 | |
CN100548282C (zh) | 一种治疗肝癌的药物 | |
CN102988906B (zh) | 一种治疗肝硬化的中药组合物 | |
CN102671056B (zh) | 一种治疗肝炎的中药组合物及其制备方法 | |
CN105617335A (zh) | 改善癌症放化疗后胆汁反流性胃炎的柴胡陷胸汤 | |
CN116983377A (zh) | 一种治疗痰浊内阻证非酒精性脂肪性肝病的中药组合物、制剂和应用 | |
CN109395047B (zh) | 一种治疗脾肾阳虚型慢性萎缩性胃炎的中药组合物及其应用 | |
CN104998158A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN111135247A (zh) | 一种治疗iv期糖尿病肾病的中药 | |
CN118320043B (zh) | 一种治疗非酒精性脂肪性肝炎的健脾通络降浊组合物 | |
CN101884714B (zh) | 一种治疗荨麻疹的中药汤剂 | |
CN117159672B (zh) | 一种预防和/或治疗难治性痛风的中药组合物及制备方法 | |
CN101167915B (zh) | 治疗慢性浅表性胃炎的中药组合物及其制备方法 | |
Jinghui et al. | The prescription rule analysis of the new theory on spleen dampness syndrome by academician TONG Xiaolin | |
CN102166303B (zh) | 一种治疗慢性萎缩性胃炎的中药组合物 | |
Yan | Professor Chang Zhanjie's Experience in the Treatment of Metabolism-Related Fatty Liver Disease by the Method of Elimination and Drainage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210302 |
|
WD01 | Invention patent application deemed withdrawn after publication |